Kp Tissue Stock Performance
| KPT Stock | CAD 10.45 0.22 2.15% |
KP Tissue has a performance score of 11 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.38, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, KP Tissue's returns are expected to increase less than the market. However, during the bear market, the loss of holding KP Tissue is expected to be smaller as well. KP Tissue today owns a risk of 0.96%. Please verify KP Tissue potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if KP Tissue will be following its current price history.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in KP Tissue are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, KP Tissue may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more
Forward Dividend Yield 0.0689 | Payout Ratio | Forward Dividend Rate 0.72 | Dividend Date 2026-01-15 | Ex Dividend Date 2025-12-31 |
1 | Investment Analysis and Advice - news.stocktradersdaily.com | 10/07/2025 |
2 | KP Tissue Stock Passes Above 200 Day Moving Average - Heres What Happened - MarketBeat | 10/24/2025 |
3 | Market Performance Analysis - news.stocktradersdaily.com | 11/07/2025 |
4 | KP Tissue Reaches New 52-Week High - Heres What Happened - MarketBeat | 11/26/2025 |
5 | Stock Trading Blueprint - news.stocktradersdaily.com | 12/09/2025 |
6 | Insider Selling KP Tissue Director Sells 3,000 Shares of Stock - MarketBeat | 12/18/2025 |
| Begin Period Cash Flow | 7 M | |
| Total Cashflows From Investing Activities | 7 M |
KPT |
KP Tissue Relative Risk vs. Return Landscape
If you would invest 957.00 in KP Tissue on September 29, 2025 and sell it today you would earn a total of 88.00 from holding KP Tissue or generate 9.2% return on investment over 90 days. KP Tissue is generating 0.1442% of daily returns assuming 0.9553% volatility of returns over the 90 days investment horizon. Simply put, 8% of all stocks have less volatile historical return distribution than KP Tissue, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
KP Tissue Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for KP Tissue's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as KP Tissue, and traders can use it to determine the average amount a KP Tissue's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1509
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | KPT | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.96 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average KP Tissue is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of KP Tissue by adding it to a well-diversified portfolio.
KP Tissue Fundamentals Growth
KPT Stock prices reflect investors' perceptions of the future prospects and financial health of KP Tissue, and KP Tissue fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on KPT Stock performance.
| Return On Equity | 0.0555 | ||||
| Current Valuation | 104.59 M | ||||
| Shares Outstanding | 10.01 M | ||||
| Price To Earning | (175.52) X | ||||
| Price To Book | 1.50 X | ||||
| EBITDA | 264.78 M | ||||
| Net Income | 2.43 M | ||||
| Total Debt | 1.8 M | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 6.94 X | ||||
| Earnings Per Share | 0.39 X | ||||
| Market Capitalization | 104.59 M | ||||
| Total Asset | 71.31 M | ||||
| Retained Earnings | (116.67 M) | ||||
About KP Tissue Performance
By examining KP Tissue's fundamental ratios, stakeholders can obtain critical insights into KP Tissue's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that KP Tissue is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.04 | |
| Return On Assets | 0.03 | 0.04 | |
| Return On Equity | 0.03 | 0.04 |
Things to note about KP Tissue performance evaluation
Checking the ongoing alerts about KP Tissue for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for KP Tissue help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Latest headline from news.google.com: Insider Selling KP Tissue Director Sells 3,000 Shares of Stock - MarketBeat |
- Analyzing KP Tissue's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether KP Tissue's stock is overvalued or undervalued compared to its peers.
- Examining KP Tissue's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating KP Tissue's management team can have a significant impact on its success or failure. Reviewing the track record and experience of KP Tissue's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of KP Tissue's stock. These opinions can provide insight into KP Tissue's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in KPT Stock
KP Tissue financial ratios help investors to determine whether KPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPT with respect to the benefits of owning KP Tissue security.